Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

9.23
+0.81009.62%
Post-market: 9.00-0.2300-2.49%19:54 EDT
Volume:93.30K
Turnover:838.26K
Market Cap:62.72M
PE:-0.81
High:9.23
Open:8.52
Low:8.48
Close:8.42
Loading ...

Atara Biotherapeutics Files Initial Beneficial Ownership Statement for Director Nachiappan Subramanian

Reuters
·
24 May

Atara Biotherapeutics Inc. Files Initial Beneficial Ownership Statement; Redmile Group's Jeremy Green Listed as Director

Reuters
·
24 May

Atara Biotherapeutics Inc. Files Initial Statement of Beneficial Ownership Naming Panacea Innovation Ltd as Owner

Reuters
·
22 May

Top Executives at Atara Biotherapeutics Make Significant Stock Sales!

TIPRANKS
·
21 May

Atara Biotherapeutics' Chief Accounting Officer Yanina Grant-Huerta Reports Disposal of Common Shares

Reuters
·
21 May

Atara Biotherapeutics CEO AnhCo Nguyen Reports Disposal of Common Shares

Reuters
·
21 May

Atara Biotherapeutics Reports Strong Q1 2025 Results

TIPRANKS
·
17 May

Atara Biotherapeutics Inc. Appoints James Huang and Nachi Subramanian to Board of Directors Following Successful $16 Million Offering

Reuters
·
17 May

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors

THOMSON REUTERS
·
17 May

Atara Biotherapeutics Announces $16M Stock Offering

TIPRANKS
·
17 May

Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting

TIPRANKS
·
16 May

BUZZ-U.S. STOCKS ON THE MOVE-Xponential Fitness, Phillips 66, Amazon.com

Reuters
·
16 May

BUZZ-Atara Biotherapeutics rises after direct stock offering, business update

Reuters
·
15 May

Atara Biotherapeutics Q1 EPS $3.50 Beats $(1.98) Estimate, Sales $98.15M Beat $5.67M Estimate

Benzinga
·
15 May

Atara Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Atara Biotherapeutics Reports Q1 2025 Net Income of $38M with EPS of $3.53, Reversing Previous Year's Loss

Reuters
·
15 May

BRIEF-Atara Biotherapeutics Q1 EPS USD 3.5

Reuters
·
15 May

Atara Biotherapeutics Inc. Announces $16 Million Share Offering to Fund Biologics License Application Activities

Reuters
·
15 May

Atara Biotherapeutics Announces First Quarter Financial Results and Operational Progress

THOMSON REUTERS
·
15 May

Atara Biotherapeutics Q1 Revenue USD 98.149 Million

THOMSON REUTERS
·
15 May